Can lurasidone (an atypical antipsychotic medication) induce mania in adults or adolescents with a history of psychiatric conditions, particularly those with bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lurasidone Induce Mania?

Yes, lurasidone can induce mania or hypomania, though this occurs in less than 1% of patients according to FDA data, and the risk appears comparable to placebo in controlled trials. 1

Evidence from FDA Drug Label

The FDA label explicitly warns that "antidepressant treatment can increase the risk of developing a manic or hypomanic episode, particularly in patients with bipolar disorder," and advises clinicians to "monitor patients for the emergence of such episodes." 1 However, in both adult bipolar depression monotherapy and adjunctive therapy studies (with lithium or valproate), less than 1% of subjects in both the lurasidone and placebo groups developed manic or hypomanic episodes. 1

Case Report Evidence

Despite the low incidence in clinical trials, a documented case exists of lurasidone-induced manic switch in a male adolescent with bipolar I depression. 2 In this case:

  • The patient was already on sodium valproate and olanzapine when lurasidone was added 2
  • Five days after adding lurasidone, the patient became manic with psychotic features 2
  • After discontinuing lurasidone, he required electroconvulsive therapy for stabilization and was switched to lithium-quetiapine combination 2
  • This case highlights the potential risk in adolescents with bipolar depression 2

Clinical Context and Risk Assessment

When Lurasidone is Used Appropriately

Lurasidone is FDA-approved specifically for bipolar I depression, both as monotherapy and adjunctive to lithium or valproate. 1, 3, 4 The mechanism of action likely involves serotonin 7 receptor antagonism, which may explain its antidepressant effects. 3

Risk Mitigation Strategy

The American Academy of Child and Adolescent Psychiatry explicitly recommends against antidepressant monotherapy in bipolar disorder due to risk of mood destabilization, mania induction, and rapid cycling. 5 While lurasidone is an atypical antipsychotic rather than a traditional antidepressant, it is used to treat bipolar depression and carries the same FDA warning about activation of mania/hypomania. 1

When prescribing lurasidone for bipolar depression:

  • Always combine with a mood stabilizer (lithium or valproate) rather than using as monotherapy in high-risk patients 5, 4
  • Monitor closely for emergence of manic or hypomanic symptoms, particularly in the first few weeks 1
  • Be especially vigilant in adolescents, where the single documented case occurred 2
  • Discontinue lurasidone immediately if manic symptoms emerge 2

Comparison to Other Atypical Antipsychotics

The risk of treatment-emergent mania with lurasidone appears lower than with traditional antidepressants but is still present. 1 Other atypical antipsychotics approved for acute mania (aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone) are used to treat mania rather than induce it. 5, 6

Common Pitfall to Avoid

Never assume that because lurasidone is an atypical antipsychotic it cannot trigger mania. 1, 2 The FDA boxed warning and documented case report demonstrate this risk is real, even if uncommon. The adolescent case is particularly instructive because the patient was already on two mood-stabilizing medications (valproate and olanzapine) when the manic switch occurred. 2

References

Research

Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2021

Research

Management of bipolar I depression: clinical utility of lurasidone.

Therapeutics and clinical risk management, 2015

Research

Lurasidone: a new treatment option for bipolar depression-a review.

Innovations in clinical neuroscience, 2015

Guideline

First-Line Treatment of Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment for Bipolar Disorder with Manic Behavior

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Should I increase lurasidone (Lurasidone) dose in a patient with bipolar disorder treated with lithium and 20mg of lurasidone (Lurasidone) who has unremitting anxiety?
Is Latuda (lurasidone) indicated for bipolar disorder?
Is there any benefit to using Latuda (lurasidone) with Trileptal (oxcarbazepine) in patients with complex or treatment-resistant psychiatric conditions, such as bipolar disorder or schizophrenia?
What alternative medication can be used for bipolar disorder if lurasidone (lurasidone) causes vaginal dryness?
How effective is lurasidone (latrepirdine) in managing psychiatric conditions in patients with chronic kidney disease (CKD)?
What is the significance of P wave inversion in lead aVR (electrocardiogram lead) in patients with potential cardiovascular disease?
What to add to telmisartan (Angiotensin II Receptor Antagonist) 40mg, cilnidipine (Calcium Channel Blocker) 10mg, and chlorthalidone (Thiazide-like Diuretic) 12.5mg twice daily for a young male patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and normal renal function, who still has uncontrolled hypertension (>140/90 mmHg)?
What is the typical PAC (Premature Atrial Contractions) sweep speed on an electrocardiogram (ECG)?
Is having four consecutive male births rare?
What antibiotic treatment is recommended for a patient with a recent ear piercing and suspected infection, considering their past medical history and potential risk of complications such as keloid formation?
What is the treatment for an adult patient with a history of trauma, surgery, or underlying conditions such as diabetes presenting with retroperitoneal gas gangrene?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.